Literature DB >> 7768376

Interleukin 1 beta induces the expression of interleukin 6 in rat intestinal smooth muscle cells.

I Khan1, M G Blennerhassett, G V Kataeva, S M Collins.   

Abstract

BACKGROUND/AIMS: The increased expression of several cytokines, including interleukin 6 (IL-6), has recently been reported in a study of the longitudinal muscle and myenteric plexus layers of rat intestine following Trichinella spiralis infection. However, the putative cellular sources and the mechanism underlying the induction of IL-6 in these tissues are presently unknown. The aim of this study was to examine the ability of cultured smooth muscle cells from rat jejunum to produce IL-6 messenger RNA and protein and to investigate the underlying mechanism.
METHODS: Cultured smooth muscle cells were treated with human recombinant interleukin 1 beta (HrIL-1 beta). The level of IL-6 messenger RNA was estimated by polymerase chain reaction, and the released IL-6 protein was estimated by bioassay.
RESULTS: HrIL-1 beta induced IL-6 messenger RNA expression in the smooth muscle cells in a time- and concentration-dependent manner. This was accompanied by the secretion of IL-6 protein into the medium. The effect of HrIL-1 beta was blocked by the IL-1 receptor antagonist, by actinomycin D, or by prior boiling of the cytokine.
CONCLUSIONS: These findings show that HrIL-1 beta interacts with its receptor on smooth muscle cells to induce transcription of the IL-6 gene and to cause the secretion of IL-6. These results indicate that intestinal smooth muscle cells are not only targets for but also a source of cytokine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768376     DOI: 10.1016/0016-5085(95)90133-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Colonic muscle enhances the production of interleukin-1 beta messenger RNA in experimental colitis.

Authors:  I Khan; F M al-Awadi
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

3.  Characteristics of inflammation-induced hypertrophy of rat intestinal smooth muscle cell.

Authors:  M G Blennerhassett; F M Bovell; S Lourenssen; K M McHugh
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

4.  Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat.

Authors:  A C Aubé; H M Blottière; C Scarpignato; C Cherbut; C Rozé; J P Galmiche
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

Review 5.  The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders.

Authors:  Tibor Docsa; Adám Sipos; Charles S Cox; Karen Uray
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

6.  Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle.

Authors:  Wenhui Hu; Fang Li; Sunila Mahavadi; Karnam S Murthy
Journal:  Biochem J       Date:  2008-05-15       Impact factor: 3.857

7.  Nintedanib regulates intestinal smooth muscle hyperplasia and phenotype in vitro and in TNBS colitis in vivo.

Authors:  Jay Kataria; Jack Kerr; Sandra R Lourenssen; Michael G Blennerhassett
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

8.  Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.

Authors:  Edmond K Ng; Ninder Panesar; Walter E Longo; Marc J Shapiro; Donald L Kaminski; Kym C Tolman; John E Mazuski
Journal:  Mediators Inflamm       Date:  2003-02       Impact factor: 4.711

9.  Pro-inflammatory mediation of myoblast proliferation.

Authors:  Jeffrey S Otis; Sarah Niccoli; Nicole Hawdon; Jessica L Sarvas; Melinda A Frye; Adam J Chicco; Simon J Lees
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.